Process Development Principal Scientist – Drug Product Technologies

Career Category

Job Description

Join Amgen’s Mission of Serving Patients

At Amgen, if you feel like you’re part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do.

Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year. Amgen is advancing a broad and deep pipeline of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases, and obesity and obesity-related conditions. As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives.

Our award-winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career.

Process Development Principal Scientist

What you will do

Let’s do this. Let’s change the world. In this vital role you will join the Pre-Pivotal Drug Product Technologies group, which is responsible for early-stage drug product development across diverse modalities, including antibody-drug conjugates (ADCs), oligonucleotides such as siRNAs, monoclonal antibodies, multispecifics, and other complex biologics. The role involves designing and developing liquid and lyophilized formulations; evaluating critical quality attributes (CQAs); establishing robust, scalable fill/finish processes; and authoring and supporting high-quality regulatory submissions.

The ideal candidate will bring hands-on experience and leadership in biologics drug product formulation, process development, and/or analytical characterization, with experience in ADCs and/or oligonucleotides such as siRNAs strongly preferred. The candidate will integrate formulation, analytical, stability, and process data to guide product design and development, including modality-specific considerations such as linker-payload attributes, stability- and process-relevant degradation pathways, ADC CQAs, oligonucleotide formulation and stability considerations, and phase-appropriate analytical strategies. This individual will apply scientific judgment, emerging technologies including AI/ML, and strong cross-functional collaboration to deliver high-quality, stable, and manufacturable drug products for clinical development in a fast-paced environment.

• Serve as a leader on Drug Product teams responsible for planning, designing, executing, and documenting laboratory studies related to drug product design, formulation, process development, technology transfer, and regulatory authoring in support of advancing Amgen’s diverse biologics pipeline.

• Work effectively in a fast-paced, matrixed environment, collaborating across process development, research, analytical, regulatory, quality, manufacturing, and external partner teams to advance programs, influence development strategies, and communicate technical recommendations to scientific peers and leadership.

• Develop and characterize liquid and lyophilized formulations for complex biologics, including ADCs, oligonucleotides, monoclonal antibodies, multispecifics, and other emerging modalities.

• Build process understanding across unit operations to support scalable drug product development.

• Evaluate in-use compatibility and drug product stability under clinically relevant conditions.

• Investigate biologics- and modality-relevant CQAs, including aggregation, fragmentation, charge and size variants, subvisible particles, surface interactions, concentration-dependent behavior, and, where applicable, ADC- or oligonucleotide-specific attributes such as drug-to-antibody ratio, free payload, linker-payload integrity, and oligonucleotide purity or degradation pathways.

• Leverage high-throughput and data-driven tools for formulation screening, stability assessment, developability evaluation, and processability characterization.

• Identify and address technology gaps impacting drug product stability, manufacturability, excipient interactions, modality-specific degradation pathways, and process-related stress responses.

• Apply machine learning, AI, automation, and data science approaches to predictive modeling, workflow acceleration, data integration, and decision-making.

• Drive continuous improvement in drug product development through scientific innovation, platform approaches, first-principles thinking, and the adoption of new technologie